SG10201601086WA - Cardiovascular therapeutics - Google Patents

Cardiovascular therapeutics

Info

Publication number
SG10201601086WA
SG10201601086WA SG10201601086WA SG10201601086WA SG10201601086WA SG 10201601086W A SG10201601086W A SG 10201601086WA SG 10201601086W A SG10201601086W A SG 10201601086WA SG 10201601086W A SG10201601086W A SG 10201601086WA SG 10201601086W A SG10201601086W A SG 10201601086WA
Authority
SG
Singapore
Prior art keywords
cardiovascular therapeutics
therapeutics
cardiovascular
Prior art date
Application number
SG10201601086WA
Other languages
English (en)
Inventor
Christopher Joseph Pemberton
Arthur Mark Richards
Christopher John Charles
Maithri Siriwardena
Original Assignee
Otago Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otago Innovation Ltd filed Critical Otago Innovation Ltd
Publication of SG10201601086WA publication Critical patent/SG10201601086WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SG10201601086WA 2011-08-18 2012-08-17 Cardiovascular therapeutics SG10201601086WA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161525140P 2011-08-18 2011-08-18

Publications (1)

Publication Number Publication Date
SG10201601086WA true SG10201601086WA (en) 2016-03-30

Family

ID=47715527

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201601086WA SG10201601086WA (en) 2011-08-18 2012-08-17 Cardiovascular therapeutics
SG11201400067TA SG11201400067TA (en) 2011-08-18 2012-08-17 Cardiovascular therapeutics

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201400067TA SG11201400067TA (en) 2011-08-18 2012-08-17 Cardiovascular therapeutics

Country Status (8)

Country Link
US (2) US9783574B2 (enrdf_load_stackoverflow)
EP (1) EP2744506B1 (enrdf_load_stackoverflow)
JP (1) JP6222779B2 (enrdf_load_stackoverflow)
CN (1) CN103889438B (enrdf_load_stackoverflow)
AU (1) AU2012296266B2 (enrdf_load_stackoverflow)
CA (1) CA2845617A1 (enrdf_load_stackoverflow)
SG (2) SG10201601086WA (enrdf_load_stackoverflow)
WO (1) WO2013024362A2 (enrdf_load_stackoverflow)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155590A (en) 1962-08-02 1964-11-03 Ncr Co Encapsulation process and its product
US3488418A (en) 1965-11-18 1970-01-06 Sterling Drug Inc Sustained relief analgesic composition
US3391416A (en) 1966-07-14 1968-07-09 Wollard Aircraft Service Equip Conveyance loader system
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
JP4181232B2 (ja) 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
US6193996B1 (en) 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac
US6410041B1 (en) 1998-04-28 2002-06-25 Trustees Of Tufts College Culturing cells in presence of amphipathic weak bases and/or cations and multiple drug resistance inhibitor containing reserpine
EP1117398A2 (en) 1998-09-28 2001-07-25 Merck & Co., Inc. A method for treating inflammatory diseases by administering a thrombin inhibitor
US20050171021A1 (en) * 1998-11-12 2005-08-04 Cormier Michel J. Buffered drug formulations for transdermal
US6309380B1 (en) 1999-01-27 2001-10-30 Marian L. Larson Drug delivery via conformal film
GB9917165D0 (en) * 1999-07-22 1999-09-22 Knoll Ag Polypeptides polynuclcotides and uses thereof
US6273831B1 (en) * 1999-09-03 2001-08-14 Callaway Golf Company Golf club head with a polymer insert
WO2005052593A1 (en) 2003-10-29 2005-06-09 The University Of Leicester Detection
WO2005072055A2 (en) * 2004-01-27 2005-08-11 Compugen Usa, Inc. Novel brain natriuretic peptide variants and methods of use thereof
DK2089722T3 (en) * 2006-09-07 2018-01-22 Otago Innovation Ltd BIOMARKET FOR EARLY DETECTION OF ACUTE HEART DISORDERS

Also Published As

Publication number Publication date
EP2744506B1 (en) 2019-10-09
AU2012296266A1 (en) 2014-03-13
WO2013024362A3 (en) 2013-07-25
US20180148475A1 (en) 2018-05-31
EP2744506A2 (en) 2014-06-25
WO2013024362A2 (en) 2013-02-21
CA2845617A1 (en) 2013-02-21
US20130072431A1 (en) 2013-03-21
SG11201400067TA (en) 2014-04-28
CN103889438A (zh) 2014-06-25
US9783574B2 (en) 2017-10-10
NZ621790A (en) 2017-09-29
EP2744506A4 (en) 2015-06-03
JP2014524435A (ja) 2014-09-22
CN103889438B (zh) 2016-08-24
JP6222779B2 (ja) 2017-11-01
AU2012296266B2 (en) 2017-08-31

Similar Documents

Publication Publication Date Title
GB2507211B (en) Trampoline
IL234056B (en) Erythrocyte binding therapies
ZA201309278B (en) Trampolines
EP2755962A4 (en) AZAINDAZOLES
EP2715659A4 (en) ABOUT FEED
EP2754063A4 (en) EXTENSIBILITY OF THE SMB2 PROTOCOL
AP2014007621A0 (en) 2-Thiopyrimidinones
SI2525128T1 (sl) Prehodni kos
GB2535351B (en) Trampoline
GB201119167D0 (en) Novel bachteriophages
GB201106538D0 (en) Coverlock
IL227377A0 (en) Combinations
SG11201400067TA (en) Cardiovascular therapeutics
AU4540P (en) BUNNAN Baloskion tetraphyllum
GB201108220D0 (en) Bungee spongee
GB201113923D0 (en) Novel combinations
GB201108290D0 (en) Solid supports
GB201116426D0 (en) Novel saccharide based therapeutics
GB201113987D0 (en) Discretion
GB201107854D0 (en) Novel 5-hydroxy-5-aryl-pyrrol-2-ones
GB201108148D0 (en) Smartcup
GB201108099D0 (en) Travelnap
GB201107872D0 (en) Globaldrum
GB201107324D0 (en) Condensafe
GB201107159D0 (en) Corcost-ZZ200